Vaccine Scheduler

Pertussis: Recommended vaccinations

	General recommendation
	Recommendation for specific groups only
	Catch-up (e.g. if previous doses missed)
	Vaccination not funded by the National Health system
	Mandatory vaccination

	Weeks	Months														Years
	6	2	3	4	5	6	8	10	11	12	13	15	16	18	19-20	2	3	4	5	6	7	8	9	10	11	12	13	14	15	16	17	18	19	20	25	45	60	≥ 61
Austria	acP¹		acP²					acP³											acP⁴					acp⁵					acp⁶

Belgium		acP	acP	acP								acP							acP									acp				acp⁷

Bulgaria		acP⁸	acP	acP									acP⁹							acP						acp						acp¹⁰

Croatia		acP		acP		acP						acP								acP¹¹				acp¹²				acp¹³				acp¹⁴

Cyprus		acP		acP		acP								acP				acP							acp							acp¹⁵

Czechia		acP¹⁶		acP					acP										acp					acp								acp¹⁷

Denmark			acP		acP					acP									acP													acp¹⁸

Estonia			acP	acP		acP										acP				acP									acp

Finland			acP		acP					acP								acP										acp			acp¹⁹

France		acP²⁰		acP					acP											acP					acp										acp²¹

Germany		acP		acP					acP	acP									acp				acp								acp	acp²²

Greece		acP		acP		acP				acP		acp			acp			acP			acp				acp		acp					acp²³

Hungary		acP	acP	acP										acP						acP					acp²⁴							acp²⁵

Iceland			acP		acP					acP								acp										acp²⁶				acp²⁶

Ireland		acP		acP		acP					acP							acP								acp²⁷						acp²⁸

Italy		acP		acP				acP											acP							acp							acp²⁹

Latvia		acP		acP		acP				acP											acP³⁰							acp				acp³¹

Liechtenstein		acP		acP						acP								acP³²				acp			acp										acp³³

Lithuania		acP		acP		acP								acP						acP									acp			acp³⁴

Luxembourg		acP	acP³⁵	acP					acP										acP										acP³⁶						acp³⁷

Malta		acP	acP	acP										acp

Netherlands		acP³⁸	acP		acP					acP									acP³⁹													acp⁴⁰

Norway			acP		acP					acP											acP								acP						acp⁴¹

Poland		wcP⁴²	wcP⁴²		wcP⁴²								wcP⁴²							acP								acp					acp⁴³

Portugal		acP		acP		acP								acP					acP													acp⁴⁴

Romania		acP		acP					acP											acP								acp				acp⁴⁵

Slovakia		acP		acP				acP											acP							acP

Slovenia			acP		acP				acP													acP							acp⁴⁶			acp⁴⁷

Spain		acP⁴⁸		acP⁴⁸					acP⁴⁸											acP⁴⁹												acp⁵⁰

Sweden			acP		acP					acP									acP									acp⁵¹				acp⁵²

Footnotes:

Primary immunisation with a hexavalent vaccine as soon as possible after the age of 6 weeks (in any case by 3 months of age)
Second dose of a hexavalent vaccine should be given 2 months after the first dose
The third dose of the hexavalent vaccine should be given 6 months after the second dose, at the age of 10–12 months
The first booster dose with a tetravalent dTaP-IPV vaccine recommended at the age of 5 years
The second booster of the tetravalent dTaP-IPV vaccine is recommended 5 years after the first booster, or latest between 13/14 years of age
After 15 years of age, booster vaccinations recommended with a dTaP vaccine every 5 years. Vaccination of pregnant women recommended but not funded, preferably in the 3rd trimester (27th-36th week of pregnancy), independent from the interval to the last vaccination against pertussis.
One dose of dTTaP every 10 years for adults after receiving the childhood immunisation schedule. Vaccination of expectant mothers during every pregnancy with a pertussis-containing vaccine in week 24 to week 32 of pregnancy. dTTaP boosters are funded for all pregnant women nationally. However, these booster doses are only offered for free in other adults in Flanders region.
Routine vaccination against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B infections, and viral hepatitis type B vaccination begins at 6 weeks of age. Second and third doses are given at week 10 and week 14. For children born to mothers vaccinated during pregnancy against pertussis, mandatory immunization against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B infections, and viral hepatitis type B is carried out from two months of age. Subsequent immunizations are administered no earlier than 4 weeks after the previous dose, at three and four months of age, respectively. For children born to mothers vaccinated during pregnancy against pertussis, mandatory immunization against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B infections, and viral hepatitis type B is carried out from two months of age. Subsequent immunizations are administered no earlier than 4 weeks after the previous dose, at three and four months of age, respectively.
Not earlier than 12 months after the 3rd dose
Immunization against pertussis is given to pregnant women between the 27th and 36th weeks of pregnancy. A booster of TDaP reduced-antigen vaccine and the administration are free of charge for pregnant women and funded by the National Health system.
Booster for children in 1st grade with DTaP-IPV or dTap-IPV
dTap booster for children in the 4th grade of primary school
dTap booster given to students in grade 8
Tdap vaccination of all pregnant women in the second and third trimester
Vaccination offered to pregnant women (one dose each pregnancy).
The first dose of hexavalent vaccine is given from the end of the 2nd month of life, at intervals of two months between the first and the second dose, and the third dose given between the eleventh and thirteenth months of the child's age
One booster dose in adulthood is recommended, 10 to 15 years after the last dose. Pertussis vaccination is also recommended for pregnant women from the 27th gestational week. Vaccination is recommended at every pregnancy.
Vaccination during pregnancy. See https://www.ssi.dk/vaccinationer/vaccination-af-gravide
dtap-vaccine for pregnant women during every pregnancy. dtap-vaccine is also given every 5 year to health and welfare workers who are working with infants.
or 8 weeks of age
For those who did not receive a dose of pertussis containing vaccine during the past 5 years, a booster with a quadrivalent vaccine (dTacp-IPV) is recommended at the time of the Td-IPV booster at 25 years. For those aged 25 years and above that did not receive a booster dose, catch-up with a dTacp-IPV vaccine can be proposed until 39 years of age. Recommendation to have an interval of 10 years in adults between a documented pertussis and pertussis re-vaccination. Vaccination offered to pregnant women from 2nd trimester and preferably between 20 and 36 weeks of pregnancy. More information available at: calendrier_vaccinal_maj-juin23.pdf (sante.gouv.fr)
The first due Td 10-yearly booster dose should be with a Tdacp vaccine. Subsequent booster doses are to be done with Td vaccines. Vaccination offered to pregnant women at the beginning of 3rd trimester. If there is an increased probability of premature birth, vaccination should be brought forward to the 2nd trimester. More information available at: RKI - Vaccinations A - Z - Scientific justification for recommending pertussis vaccination with a Tdap combination vaccine in pregnancy
Booster dose 18- 25 y with Tdap or Tdap-IPV, followed by Td or Tdap every 10 y. A single dose of Tdap or Tdap-IPV vaccine should be administered in each pregnancy, preferably from 27 to 36 weeks of gestation, as well as to unvaccinated women who have recently given birth, regardless of the interval between previous Tdacp vaccination.
School-based vaccination in 6th grade (mandatory)
Vaccination offered to pregnant women between 16 and 32 weeks of pregnancy. More information available at: Vacsatc - Vaccine safety | Professional sites | Vaccination methodology letter 2023
Repeat for pregnant women in second or third trimester of every pregnancy regardless of the time since last vaccination.
Booster dose d, TT acP
Tdap - Vaccination for pregnant women between 16-36 weeks gestation.
Tdap is recommended every 10 years from age 19, and also for pregnant women in the third trimester (ideally 28 weeks)
Six-year-old children may be vaccinated with vaccinations for 7-year-old children, if the child is beginning to study in an educational institution.
Pertussis antigen during pregnancy
A lower dose of diphtheria toxoid (d) and whooping cough (ap) can also be used (dTap) The pertussis booster provided between the ages of 4 and 7 years should be administered no later than school entry.
Booster at 25 years (dTap), 45 years (dT) and 65 years (dT), and then every 10 years (dT)
Vaccination during pregnancy
For premature infants (born before 33 weeks) or with a birthweight <1500g, a 3+1 schedule is recommended
One booster dose of Tdacp-IPV in this age group.
One booster dose every 10 years. Vaccination for pregnant women between 13-26 weeks gestation - Tdap or TdapIPV vaccine
This additional vaccination is recommended only for infants at 2 months of age whose mothers were not vaccinated during pregnancy, and in specific circumstances. In all other cases, infants born to mothers vaccinated during pregnancy (at 22 weeks gestation) receive a two-dose primary series at 3 and 5 months of age.
starting cohort 2021
Recommended for pregnant women from the 22nd weeks of pregnancy until delivery (in every pregnancy)
Revaccination every 10 years. Vaccination during pregnancy in week 24, but catch-up vaccination can be accommodated until birth. https://www.fhi.no/en/va/childhood-immunisation-programme/when-will-your-child-be-offered-vaccines/#during-pregnancy
An acellular pertussis component (aP) combination vaccine should be used for children with contraindications to vaccination with the whole cell pertussis vaccine and in children born before 37th week of pregnancy or born with birth weight less than 2500 g
One booster doses every 10 years is recommended.Vaccination offered to pregnant women between 27 and 36 weeks of pregnancy and ideally between 28 and 32 weeks of pregnancy. More information available at: Kalendarz szczepien 2023 Kobiet w ciazy (pzh.gov.pl) and https://szczepienia.pzh.gov.pl/kalendarz-szczepien-doroslych/
Tdap vaccination recommended during pregnancy in all ages between 20 to 36 weeks of gestation. More information available at: https://www.dgs.pt/ficheiros-de-upload-2013/39-tosse-convulsa-pdf.aspx
Vaccination during pregnancy
From 2023 onwards, TT was replaced by dTacp
Pregnant women: 1 dose Tdap vaccine recommended from the 24th week of pregnancy. see https://nijz.si/nalezljive-bolezni/cepljenje/cepljenje-nosecnic/
For more detail on review and recommendation for pertussis vaccination in Spain, please refer to https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/comoTrabajamos/difteria-tetanos-tosferina.htm
For more detail on review and recommendation for pertussis vaccination in Spain, please refer to https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/comoTrabajamos/docs/TosFerina.pdf
Repeat for pregnant women starting at week 27 of pregnancy (preferably at week 27 or 28). Additional information available at: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/calendario/docs/CalendarioVacunacion_Todalavida.pdf
Given to 8-9 grade students.
Vaccination offered to pregnant women after 16 weeks of pregnancy. More information available at: https://www.folkhalsomyndigheten.se/smittskydd-beredskap/vaccinationer/vaccinationer-till-vuxna/